title: Sustained response to salvage therapy for dabrafenib-resistant metastatic Langerhans cell sarcoma.
authors: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, National Reference Center for Langerhans cell histiocytosis, Pulmonology Department, Paris, France.
authors: G
authors: G
authors: Lorillon
authors: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Pharmacology and Genetic Department, Paris, France.|Univ Paris-Diderot, Sorbonne Paris Cité; INSERM U976, Paris, France.
authors: S
authors: S
authors: Mourah
authors: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Nuclear Medicine Department, Paris, France.
authors: L
authors: L
authors: Vercellino
authors: Univ. Paris-Diderot, Sorbonne Paris Cité; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Radiology Department, Paris, France.
authors: C
authors: C
authors: de Margerie-Mellon
authors: Assistance Publique-Hôpitaux de Paris, Dermatology Department, Paris, France.
authors: C
authors: C
authors: Pagès
authors: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Pharmacology and Genetic Department, Paris, France.
authors: L
authors: L
authors: Goldwirt
authors: Univ Paris-Diderot, Sorbonne Paris Cité; INSERM U976, Paris, France.|Assistance Publique-Hôpitaux de Paris, Dermatology Department, Paris, France.
authors: C
authors: C
authors: Lebbe
authors: Laboratory for Epigenetics and Environment, Genotyping National Center, CEA-Genomic Institute, Evry, France.
authors: J
authors: J
authors: Tost
authors: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, National Reference Center for Langerhans cell histiocytosis, Pulmonology Department, Paris, France abdellatif.tazi@aphp.fr.|Univ Paris-Diderot, Sorbonne Paris Cité; CRESS INSERM U1153, Biostatistics and Clinical Epidemiology Research Team, Paris, France.
authors: A
authors: A
authors: Tazi
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D054752:Langerhans Cell Sarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010091:Oximes / Q000494:pharmacology / Q000627:therapeutic use*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D016879:Salvage Therapy / Q000639:trends*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D010091:Oximes; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; C561627:dabrafenib